A new study led by the one of the only people permitted by the U.S. government to grow marijuana for research purposes finds that cannabis available across the country is “basically the same” in terms of its primary cannabinoid content. Genetics, the paper says—not regional growing differences—are chiefly responsible for the chemical makeup of the plant.
“Data showed that the cannabinoids profile of all high Δ9-THC cannabis samples, regardless of the state or region from which the samples are seized or the state from which the sample is produced under a state medical marijuana program, is basically the same,” the paper claims, reporting that samples analyzed averaged between 10 percent and 20 percent THC.
Another of the study’s claims, however, may be more controversial: The report asserts that marijuana available to consumers in state-legal markets is not only similar across the country but also “very similar to the chemical profile of the research cannabis” available through the National Institute on Drug Abuse (NIDA) Drug Supply Program—a program that several years ago came under fire for providing allegedly substandard marijuana for research purposes.
“The chemical profile of the illicit cannabis in the different regions of the USA as well as the
Read full article on Marijuana Moment
